Biotech news
Asia-Pacific
Legislative developments surrounding supplementary protection certificates in the EU are moving fast, and may be catching on as far afield as Australia. Gareth Morgan of Olswang explains more. 7 July 2016
Pharma
Following the UK’s vote to leave the EU, it is business as usual for life sciences companies working with intellectual property, at least for now, says Claire Phipps-Jones of Bristows. 7 July 2016
Americas
The US Court of Appeals for the Federal Circuit ruled yesterday in the Amgen v Apotex case that bisoimilars companies must always notify brand name rivals 180 days before launching their products. 6 July 2016
Americas
The Biotechnology Innovation Organisation has welcomed Hillary Clinton’s plans to improve the US’s patent system. 30 June 2016
Pharma
The UK’s vote to leave the EU has triggered an immediate need for innovative life sciences companies to evaluate the impact on their patent strategies, argues Laetitia Benard of Allen & Overy. 30 June 2016
Biotech
Is it time for healthcare regulators and patent offices to limit the strategies used by existing biologic manufacturers and allow new suppliers to reach some of the world’s most lucrative healthcare systems? Elizabeth Ward of Virtuoso Legal investigates. 30 June 2016
Asia
Indonesian lawmakers have announced that hospitals and health clinics are being investigated by authorities after police exposed a group selling fake vaccines aimed at children for more than a decade. 29 June 2016
Americas
The US Supreme Court announced yesterday that it has agreed to hear a patent infringement case between Promega and Life Technologies centring on DNA testing kits used to analyse genetic differences between people. 28 June 2016
Americas
The US Supreme Court has today made its decision to deny a review of the patent dispute between Sequenom and Ariosa Diagnostics over a patent covering pre-natal testing. 27 June 2016
Americas
UK-based diagnostics company Oxford Immunotec has announced that it will acquire Imugen, a US clinical laboratory, for $22.2 million in cash. 27 June 2016